Jena, Germany / Besançon, France – Carl Zeiss and Digital Surf announce the signing of an agreement enabling Carl Zeiss to provide ConfoMap® software. ConfoMap® is a surface imaging and analysis software for confocal microscopes and compound microscopes for topographical research. “Carl Zeiss confocal microscopes provide strong support for the development of new materials and […]
PARIS and SEATTLE – Cellectis (Alternext: ALCLS), the French genome engineering specialist, announced today the signing of a collaboration agreement with Pregenen, an American biotechnology start-up company dedicated to the creation of innovative tools for genome engineering. Pregenen is a spinoff from the Northwest Genome Engineering Consortium, a group that brings in renowned international researchers […]
ESSEN, Germany – Elster (NYSE: ELT) announced today that the company has acquired the gas chromatography assets, including sophisticated proprietary intellectual property, from SLS Micro Technology (SLS), a private company based in Hamburg, Germany. The SLS technology is especially effective at assessing downstream gas quality as gases from different sources, including biogas, shale gas and […]
WALTHAM, Mass. – Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, today announced that its collaboration with the Health Protection Agency (HPA) in the U.K. has led to a significant development in mapping the proteome of the organism responsible for the recent E. coli outbreak in Europe. Using Thermo Scientific LTQ Orbitrap […]
Sydney, Australia – NuSep (ASX: NSP) wishes to advise the market that it has signed a new three year Gels distribution agreement with Thermo Fisher Scientific. This agreement has a minimum guaranteed purchases commitment of US$850,000 over the first 15 months. This distribution agreement will provide access to NuSep’s nUView gels in the Bio-Rad and […]
AUSTIN, Texas – Luminex Corporation (NASDAQ: LMNX) today announced the completion of its acquisition of privately-held EraGen Biosciences, Inc., an innovator in molecular diagnostic testing technologies for infectious disease and genetic applications, for $34 million in cash. Luminex expects the EraGen acquisition will add between $5 million and $7 million to 2011 consolidated revenue. On […]
GENEVA – At the 4th Congress of European Microbiologists (Federation of European Microbiological Societies, or FEMS), Bruker announces the extension of its agreement with the private diagnostic laboratory Viollier AG (https://www.viollier.ch), one of the leading Swiss diagnostic laboratories, located in Basel. Viollier has used Bruker’s MALDI Biotyper system for MALDI-TOF mass spectrometry-based microbial identification now […]
SANTA CLARA Calif. – Agilent Technologies Inc. (NYSE: A) today announced that its Cedar Creek, Texas, reagent manufacturing facility has been registered with the U.S. Food and Drug Administration as a medical device establishment. This registration is required for the manufacture of diagnostic products, which Agilent intends to develop. “Many of Agilent’s proven research platforms […]
GENEVA – At the 4th Congress of European Microbiologists (FEMS 2011), Bruker announces the amendment of its exclusive distribution agreement for clinical microbiology for Bruker’s MALDI Biotyper with Francisco Soria Melguizo S.A. to cover now also Portugal, as another territory in addition to Spain. Francisco Soria Melguizo is one of the market leaders for clinical […]
GENEVA – At the 4th Congress of European Microbiologists (Federation of European Microbiological Societies, or FEMS) meeting in Geneva, Bruker announces a collaboration with the Institute of Medical Microbiology (IMM) at the University of Zurich (https://www.imm.uzh.ch). The IMM is using Bruker’s MALDI Biotyper system as their next-generation, rapid microbial identification system. The Institute of Medical […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
